Target-induced SOFA-HDV ribozyme

Methods in Molecular Biology

Volumn 848, Issue , 2012, Pages 369-384

  Lévesque, Michel V ^a   Perreault, Jean Pierre ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Functional genomics; Gene inactivation; Gene therapy; Ribozyme

Indexed keywords

RIBOZYME;

ARTICLE; DOCUMENTATION; ENZYME SPECIFICITY; ENZYMOLOGY; GENETIC ENGINEERING; GENETICS; HEPATITIS DELTA VIRUS; METABOLISM; METHODOLOGY; NUCLEOTIDE SEQUENCE;

BASE SEQUENCE; DOCUMENTATION; GENETIC ENGINEERING; HEPATITIS DELTA VIRUS; RNA, CATALYTIC; SUBSTRATE SPECIFICITY;

EUKARYOTA; HEPATITIS DELTA VIRUS; PROKARYOTA;

EID: 84858257782     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-545-9_23     Document Type: Article

References (23)

1. Bagheri, S., and Kashani-Sabet, M. (2004) Ribozymes in the Age of Molecular Therapeutics. Curr. Mol. Med. 4, 489-506. (Pubitemid 38961193)
2. Schubert, S., and Kurreck, J. (2004) Ribozymeand Deoxyribozyme-Strategies for Medical Applications. Curr. Drug Targets. 5, 667-681.
3. Asif-Ullah, M., Levesque, M., Robichaud, G., and Perreault, J. P. (2007) Development of Ribozyme-Based Gene-Inactivations; the Example of the Hepatitis Delta Virus Ribozyme. Curr. Gene Ther. 7, 205-216. (Pubitemid 46902202)
4. Tedeschi, L., Lande, C., Cecchettini, A., and Citti, L. (2009) Hammerhead Ribozymes in Therapeutic Target Discovery and Validation. Drug Discov. Today. 14, 776-783.
5. Teixeira, A., Tahiri-Alaoui, A., West, S., Thomas, B., Ramadass, A., Martianov, I., Dye, M., James, W., Proudfoot, N. J., and Akoulitchev, A. (2004) Autocatalytic RNA Cleavage in the Human Beta-Globin PremRNA Promotes Transcription Termination. Nature. 432, 526-530. (Pubitemid 39576536)
6. Salehi-Ashtiani, K., Luptak, A., Litovchick, A., and Szostak, J. W. (2006) A Genomewide Search for Ribozymes Reveals an HDV-Like Sequence in the Human CPEB3 Gene. Science. 313, 1788-1792. (Pubitemid 44454155)
7. Levesque, D., Choufani, S., and Perreault, J. P. (2002) Delta Ribozyme Benefits from a Good Stability in Vitro that Becomes Outstanding in Vivo. RNA. 8, 464-477. (Pubitemid 34437717)
8. Bergeron, L. J., Ouellet, J., and Perreault, J. P. (2003) Ribozyme-Based Gene-Inactivation Systems Require a Fine Comprehension of their Substrate Specificities; the Case of Delta Ribozyme. Curr. Med. Chem. 10, 2589-2597. (Pubitemid 37456028)
9. Peracchi, A. (2004) Prospects for Antiviral Ribozymes and Deoxyribozymes. Rev. Med. Virol. 14, 47-64. (Pubitemid 38133625)
10. Bergeron, L. J., and Perreault, J. P. (2005) Target-Dependent on/off Switch Increases Ribozyme Fidelity. Nucleic Acids Res. 33, 1240-1248. (Pubitemid 41439917)
11. Bergeron, L. J., Reymond, C., and Perreault, J. P. (2005) Functional Characterization of the SOFA Delta Ribozyme. RNA. 11, 1858-1868. (Pubitemid 41720035)
12. Fiola, K., Perreault, J. P., and Cousineau, B. (2006) Gene Targeting in the Gram-Positive Bacterium Lactococcus lactis, using various Delta Ribozymes. Appl. Environ. Microbiol. 72, 869-879.
13. Bergeron, L. J., Reymond, C., and Perreault, J. P. (2005) Functional Characterization of the SOFA Delta Ribozyme. RNA. 11, 1858-1868. (Pubitemid 41720035)
14. Levesque, M. V., Levesque, D., Briere, F. P., and Perreault, J. P. (2010) Investigating a New Generation of Ribozymes in Order to Target HCV. PLoS One. 5, e9627.
15. Robichaud, G. A., Perreault, J. P., and Ouellette, R. J. (2008) Development of an Isoform-Specific Gene Suppression System: The Study of the Human Pax-5B Transcriptional Element. Nucleic Acids Res. 36, 4609-4620.
16. von Eije, K. J., ter Brake, O., and Berkhout, B. (2008) Human Immunodeficiency Virus Type 1 Escape is Restricted when Conserved Genome Sequences are Targeted by RNA Interference. J. Virol. 82, 2895-2903. (Pubitemid 351329179)
17. Haasnoot, J., Westerhout, E. M., and Berkhout, B. (2007) RNA Interference Against Viruses: Strike and Counterstrike. Nat. Biotechnol. 25, 1435-1443. (Pubitemid 350233142)
18. Amarzguioui, M., Brede, G., Babaie, E., Grotli, M., Sproat, B., and Prydz, H. (2000) Secondary Structure Prediction and in Vitro Accessibility of mRNA as Tools in the Selection of Target Sites for Ribozymes. Nucleic Acids Res. 28, 4113-4124.
19. Ryu, K. J., and Lee, S. W. (2004) Comparative Analysis of Intracellular Trans-Splicing Ribozyme Activity Against Hepatitis C Virus Internal Ribosome Entry Site. J. Microbiol. 42, 361-364.
20. Doran, G., and Sohail, M. (2006) Systematic Analysis of the Role of Target Site Accessibility in the Activity of DNA Enzymes. J. RNAi Gene Silencing. 2, 205-214.
21. Deschenes, P., Lafontaine, D. A., Charland, S., and Perreault, J. P. (2000) Nucleotides-1 to-4 of Hepatitis Delta Ribozyme Substrate Increase the Specificity of Ribozyme Cleavage. Antisense Nucleic Acid Drug Dev. 10, 53-61. (Pubitemid 30148190)
22. Lucier, J. F., Bergeron, L. J., Briere, F. P., Ouellette, R., Elela, S. A., and Perreault, J. P. (2006) RiboSubstrates: A Web Application Addressing the Cleavage Specificities of Ribozymes in Designated Genomes. BMC Bioinformatics. 7, 480.
23. Ouellet, J., and Perreault, J. P. (2004) Cross-Linking Experiments Reveal the Presence of Novel Structural Features between a Hepatitis Delta Virus Ribozyme and its Substrate. RNA. 10, 1059-1072. (Pubitemid 38822142)